Last reviewed · How we verify
NCT04610216
Investigation of the Automatic Technology on the Naída M Hearing Devices
trial testing Naida CI M hearing device in Cochlear Hearing Loss in 12 participants. Completed in 23 September 2021.
23 September 2021
Quick facts
| Lead sponsor | Advanced Bionics AG |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 12 |
| Start date | 20 October 2020 |
| Primary completion | 23 September 2021 |
| Estimated completion | 23 September 2021 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Naida CI M hearing device
Conditions studied
- Cochlear Hearing Loss — all drugs for Cochlear Hearing Loss →
Sponsor
Advanced Bionics AG — full company profile →
Who can join
18 and older, any sex, with Cochlear Hearing Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this clinical trial, an un-controlled, repeated measures open design with within-subject comparison will be used to evaluate the effect of the device under investigation on sound perception. This design was shown to be successful in previous studies for the evaluation of sound coding strategies. Furthermore, a within-subject comparison decreases the variance in the results allowing for fewer subjects when the population using the investigational device is not large in general.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04610216
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cochlear Hearing Loss
Currently open trials in the same condition.
- NCT07509788 — Effects of Binaural Hearing on Listening Effort and Cognitive Development in Mandarin-speaking Children With Cochlear Im · recruiting
- NCT07068373 — Development of Evidence-based Therapeutic Guidelines for Early SLA in Urdu-speaking Children With Cochlear Implants · active not recruiting
- NCT06960616 — Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy · NA · recruiting
- NCT05486637 — Vocal Emotion Communication With Cochlear Implants · EARLY_PHASE1 · recruiting
Other Advanced Bionics AG trials
Trials by the same sponsor.
- NCT06268340 — Hearing and Structure Preservation Via ECochG · NA · recruiting
- NCT06301568 — Retrospective Analysis of Long-term Speech Performance in Cochlear Implant Recipients Using Electro-acoustic Stimulation · completed
- NCT04815343 — Investigation of the Naída CI M90 Sound Processor in Various Acoustic Scenarios · NA · completed
- NCT04610112 — Safety and Performance of HiRes Ultra/Ultra 3D Cl Mid-Scala Electrodes in Adults With Severe-to-profound Hearing Loss · completed
- NCT03078920 — Benefits of a Contralateral Routing of Signals (CROS) System in Unilateral CI-recipients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04610216 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Advanced Bionics AG
- Last refreshed: 1 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04610216.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing